Healthcare -
Biotechnology - NASDAQ - US
$ 1.385
-7.04 %
$ 882 M
Market Cap
-4.89
P/E
GERN - REVENUE
Revenue GERN - Geron Corporation
77 M
LAST VALUE
1036.59%
2 YEAR CAGR
178.45%
5 YEAR CAGR
52.22%
10 YEAR CAGR